No Prostate Cancer PSA Screening Recommended By U.S. Health Panel

October 7, 2011 by  
Filed under Prostate Cancer News

In a move that’s clearly going to stir the hornets nest, the U.S. health panel is going to recommend that all healthy men under the ages of 75 stop going for prostate cancer PSA screening.

Just like every major information source on prostate cancer, we have always advocated early screening to detect this cancer because early detection leads to better chances of surviving this condition. So, this new move is a shock, even to us.

It’s true that PSA testing sometimes leads to false positives, leading to even more tests to determine whether there is cancer or not, but is that enough to recommend stopping the screenings altogether?

Read more on this below:


The U.S. Preventive Services Task Force is set to recommend that middle-aged men skip routine screening for prostate cancer, according to reports circulating Thursday.

The task force, which sets disease prevention policies for the federal government, is scheduled to issue its new recommendations Tuesday, according to the Santa Monica-based Prostate Cancer Foundation. But the New York Times and a weekly newsletter known as the Cancer Letter reported Thursday that the task force would change its position on the widely used PSA test to recommend that men under age 75 forgo it.

The chairwoman of the task force, Dr. Virginia Moyer of Baylor College of Medicine in Houston, could not be reached for comment Thursday.

Such a change would be controversial. Although a series of clinical studies has raised questions about the benefits of the test, many doctors maintain that it is valuable.

“That would be a very big surprise for the urology community,” said Dr. Milton Krisiloff, a urologist at St. John’s Health Center in Santa Monica. “Prostate cancer kills a lot of people. It’s not an innocuous disease. If they say just eliminate PSA, then a lot of people are going to die.”

Many doctors and patients had the same complaint in 2009, when the task force softened its endorsement of mammography as a screening tool for breast cancer. The panel said that routine testing for women of average risk should begin at age 50 instead of 40 and that mammograms should be done only once every two years. Those recommendations have largely been ignored.

The PSA test for prostate cancer looks for prostate-specific antigen, a protein produced in the prostate that helps make semen. A small amount of PSA typically circulates in the blood of healthy men. Levels above 4 nanograms per milliliter of blood could indicate the presence of prostate cancer.

The problem with the test, critics say, is that it flags too many patients for follow-up procedures that can be expensive and sometimes risky. Among men with results in the range of 4 to 10 ng/ml, biopsies show that 70% will have false-positive results and 30% will have prostate cancer. In addition, the disease is frequently slow-growing and causes no harm if left unchecked.

About 20 million American men have a PSA test each year. The National Cancer Institute says that 240,000 men are diagnosed with prostate cancer in the U.S. each year, and 33,720 die.

In 2008, the task force said that men over the age of 75 should stop getting routine PSA tests. But it added that there was “insufficient evidence” to recommend PSA screening for men younger than 75.

The American Cancer Society reviewed the evidence in 2009 and said that it remained unclear whether PSA screening saved lives. The society recommends men of average risk talk to their doctors about screening beginning at age 50 and that higher-risk men discuss screening at 45.

The American Urological Assn. currently recommends that men over 40 talk to their doctors about PSA screening.

Studies have shown that PSA screening detects more prostate cancers but does not lower death rates from the disease. Though some cases of prostate cancer are aggressive, others are so slow-growing that treatment is unnecessary.

Only a biopsy can confirm the presence of cancer. A European study published in the New England Journal of Medicine in 2009 found that about 1,400 men would need to be screened and 48 treated to prevent one death from the disease.

A bigger issue than the PSA test is how men are treated for prostate cancer, said Dr. Karim Chamie, a urologist at UCLA’s Jonsson Comprehensive Cancer Center. Read the full news article in the LA times.


It will be interesting to see how this goes.

See a video on CNN about this No Prostate Cancer PSA Screening Recommended By U.S. Health Panel:

We will provide additional information on this if the recommendation is adhered to.


Below Are Other Related Articles Among 1,000+ Prostate Cancer Articles On
This HUGE 4+ Year Old Prostate Cancer Victory Authority Website:

(95% of these 1,000+ Prostate Cancer Articles on this website
are written by our Expert In -house Writers, after lots of research.
The remaining 5% are news articles and videos from relevant sources!)

  1. Diagnosis And Treatment Health Prostate Cancer – Early Screening
  2. PSA Prostate Cancer Screening – Who Needs It?
  3. Why Prostate Cancer Screening Programs Are Important
  4. Prostate Cancer Exam – Screening And Tests
  5. Prostate Cancer PSA Level – The Importance
  6. Prostrate Cancer PSA Test – It’s Not Always What They Say
  7. New More Effective PSA Test Method For Detecting Prostate Cancer?
  8. Prostate Cancer Psa Test – Diagnosing And Staging
  9. Prostate Specific Antigen (PSA) Test – 7 Important Facts To Help You
  10. Why You Should Do A Prostate Cancer Psa Test Today
  11. Prostate Cancer Symptoms Screening and Diagnosis
  12. Are You This Wrong About Prostate Cancer Screening?
  13. Prostate Cancer Psa Test
  14. Psa Level Prostate Cancer – What You Have Not Been Told
  15. Health Promotions Program on Prostate Cancer – Oregon Health and Science University

Speak Your Mind

Tell us what you're thinking... !